Standardised quantitative radioiodine SPECT/CT Imaging for multicentre dosimetry trials in molecular radiotherapyRebecca Gregory, Glenn Flux, Jill Tipping et al.|Physics in Medicine and Biology|2019Cited by 48
Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trialSarah Brown, Jonathan Wadsley, Andrew Hall et al.|BMC Cancer|2019Cited by 39
SELIMETRY—a multicentre I-131 dosimetry trial: a clinical perspectiveJonathan Wadsley, Sarah Brown, Glenn Flux et al.|British Journal of Radiology|2017Cited by 32
The Role of Pretherapy Quantitative Imaging and Dosimetry in Radioiodine Therapy for Advanced Thyroid CancerJ. Taprogge, Glenn Flux, Carla Abreu et al.|Journal of Nuclear Medicine|2023Cited by 19